ACVR1B and BMPR2 |
activin A receptor type 1B |
bone morphogenetic protein receptor type 2 |
- Signaling by NODAL
- Regulation of signaling by NODAL
- Signaling by Activin
|
|
|
|
|
|
ACVR2A and BMP4 |
activin A receptor type 2A |
bone morphogenetic protein 4 |
- Signaling by NODAL
- Regulation of signaling by NODAL
- Signaling by Activin
- Signaling by Activin
- Signaling by BMP
|
- Molecules associated with elastic fibres
- Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
- Post-translational protein phosphorylation
|
|
|
|
- Anophthalmia and microphthalmia (A/M)
|
ACVR2A and BMP6 |
activin A receptor type 2A |
bone morphogenetic protein 6 |
- Signaling by NODAL
- Regulation of signaling by NODAL
- Signaling by Activin
- Signaling by Activin
- Signaling by BMP
|
|
|
|
|
|
ADA and SGCD |
adenosine deaminase |
sarcoglycan delta |
|
|
- Pentostatin
- Dipyridamole
- FR221647
- 6-Hydroxy-7,8-Dihydro Purine Nucleoside
- FR117016
- FR236913
- 6-Hydroxy-1,6-Dihydro Purine Nucleoside
- FR233623
- FR239087
- FR230513
- 1-Deaza-Adenosine
- Nebularine
- (2S,3R)-3-(6-amino-9H-purin-9-yl)nonan-2-ol
- 1-((1R)-1-(HYDROXYMETHYL)-3-{6-[(3-PHENYLPROPANOYL)AMINO]-1H-INDOL-1-YL}PROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE
- 1-{(1R,2S)-2-HYDROXY-1-[2-(2-NAPHTHYLOXY)ETHYL]PROPYL}-1H-IMIDAZONE-4-CARBOXAMIDE
- 1-((1R,2S)-1-{2-[2-(4-CHLOROPHENYL)-1,3-BENZOXAZOL-7-YL]ETHYL}-2-HYDROXYPROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE
|
|
- T-B-Severe combined immunodeficiencies (SCIDs), including the following four diseases: Adenosine deaminase (ADA) deficiency; Recombinase activating gene (RAG) deficiencies; Artemis deficiency; Reticular dysgenesis
|
|
ADARB1 and PIN1 |
adenosine deaminase RNA specific B1 |
peptidylprolyl cis/trans isomerase, NIMA-interacting 1 |
- C6 deamination of adenosine
- Formation of editosomes by ADAR proteins
|
- ISG15 antiviral mechanism
- RHO GTPases Activate NADPH Oxidases
- Regulation of TP53 Activity through Phosphorylation
- PI5P Regulates TP53 Acetylation
- Negative regulators of DDX58/IFIH1 signaling
|
|
- Beta-(2-Naphthyl)-Alanine
- 3,6,9,12,15,18-HEXAOXAICOSANE
|
|
|
ADARB1 and APP |
adenosine deaminase RNA specific B1 |
amyloid beta precursor protein |
- C6 deamination of adenosine
- Formation of editosomes by ADAR proteins
|
- Platelet degranulation
- ECM proteoglycans
- Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
- G alpha (q) signalling events
- G alpha (i) signalling events
- Lysosome Vesicle Biogenesis
- Formyl peptide receptors bind formyl peptides and many other ligands
- TAK1 activates NFkB by phosphorylation and activation of IKKs complex
- The NLRP3 inflammasome
- Advanced glycosylation endproduct receptor signaling
- Advanced glycosylation endproduct receptor signaling
- Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models
- Post-translational protein phosphorylation
- TRAF6 mediated NF-kB activation
- Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
- Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
- Purinergic signaling in leishmaniasis infection
- Amyloid fiber formation
|
|
- Deferoxamine
- Aluminium
- Zinc
- L-methionine (R)-S-oxide
- Resveratrol
- Phenserine
- Tiomolibdate ion
- CAD106
- Mito-4509
- Dimercaprol
- Copper
- Florbetaben (18F)
- Florbetapir (18F)
- Flutemetamol (18F)
|
|
|
ADCY2 and ADCY5 |
adenylate cyclase 2 |
adenylate cyclase 5 |
- Glucagon signaling in metabolic regulation
- PKA activation
- PKA activation in glucagon signalling
- Adenylate cyclase activating pathway
- Adenylate cyclase inhibitory pathway
- Adenylate cyclase inhibitory pathway
- G alpha (s) signalling events
- G alpha (s) signalling events
- G alpha (i) signalling events
- G alpha (z) signalling events
- G alpha (z) signalling events
- Vasopressin regulates renal water homeostasis via Aquaporins
- Hedgehog 'off' state
- ADORA2B mediated anti-inflammatory cytokines production
- ADORA2B mediated anti-inflammatory cytokines production
- FCGR3A-mediated IL10 synthesis
|
- Glucagon signaling in metabolic regulation
- PKA activation
- PKA activation in glucagon signalling
- Adenylate cyclase activating pathway
- Adenylate cyclase inhibitory pathway
- Adenylate cyclase inhibitory pathway
- Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
- Adrenaline,noradrenaline inhibits insulin secretion
- G alpha (s) signalling events
- G alpha (s) signalling events
- G alpha (i) signalling events
- G alpha (z) signalling events
- G alpha (z) signalling events
- Vasopressin regulates renal water homeostasis via Aquaporins
- Hedgehog 'off' state
- ADORA2B mediated anti-inflammatory cytokines production
- ADORA2B mediated anti-inflammatory cytokines production
- FCGR3A-mediated IL10 synthesis
|
- Colforsin
- 2',5'-DIDEOXY-ADENOSINE 3'-MONOPHOSPHATE
|
- Colforsin
- 2',5'-DIDEOXY-ADENOSINE 3'-MONOPHOSPHATE
|
|
|
ADCY3 and CAMK2G |
adenylate cyclase 3 |
calcium/calmodulin dependent protein kinase II gamma |
- Glucagon signaling in metabolic regulation
- PKA activation
- PKA activation in glucagon signalling
- Adenylate cyclase activating pathway
- Adenylate cyclase inhibitory pathway
- Adenylate cyclase inhibitory pathway
- G alpha (s) signalling events
- G alpha (s) signalling events
- G alpha (i) signalling events
- G alpha (z) signalling events
- G alpha (z) signalling events
- Vasopressin regulates renal water homeostasis via Aquaporins
- Hedgehog 'off' state
- ADORA2B mediated anti-inflammatory cytokines production
- ADORA2B mediated anti-inflammatory cytokines production
- FCGR3A-mediated IL10 synthesis
|
- CaMK IV-mediated phosphorylation of CREB
- HSF1-dependent transactivation
- Trafficking of AMPA receptors
- Unblocking of NMDA receptors, glutamate binding and activation
- Unblocking of NMDA receptors, glutamate binding and activation
- CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde
- Ras activation upon Ca2+ influx through NMDA receptor
- Phase 0 - rapid depolarisation
- Ion homeostasis
- RAF activation
- RAF/MAP kinase cascade
- Signaling by moderate kinase activity BRAF mutants
- Signaling by BRAF and RAF fusions
- Paradoxical activation of RAF signaling by kinase inactive BRAF
- Interferon gamma signaling
- Regulation of MECP2 expression and activity
- Ion transport by P-type ATPases
- Assembly and cell surface presentation of NMDA receptors
- Negative regulation of NMDA receptor-mediated neuronal transmission
- Long-term potentiation
- Signaling downstream of RAS mutants
|
|
- Bosutinib
- 1-tert-butyl-3-(3-methylbenzyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
|
|
|
ADCY5 and PRKCA |
adenylate cyclase 5 |
protein kinase C alpha |
- Glucagon signaling in metabolic regulation
- PKA activation
- PKA activation in glucagon signalling
- Adenylate cyclase activating pathway
- Adenylate cyclase inhibitory pathway
- Adenylate cyclase inhibitory pathway
- Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
- Adrenaline,noradrenaline inhibits insulin secretion
- G alpha (s) signalling events
- G alpha (s) signalling events
- G alpha (i) signalling events
- G alpha (z) signalling events
- G alpha (z) signalling events
- Vasopressin regulates renal water homeostasis via Aquaporins
- Hedgehog 'off' state
- ADORA2B mediated anti-inflammatory cytokines production
- ADORA2B mediated anti-inflammatory cytokines production
- FCGR3A-mediated IL10 synthesis
|
- Calmodulin induced events
- Disinhibition of SNARE formation
- SHC1 events in ERBB2 signaling
- Signaling by SCF-KIT
- Regulation of KIT signaling
- EGFR Transactivation by Gastrin
- Inactivation, recovery and regulation of the phototransduction cascade
- Syndecan interactions
- Acetylcholine regulates insulin secretion
- Ca2+ pathway
- Trafficking of GluR2-containing AMPA receptors
- G alpha (z) signalling events
- Depolymerisation of the Nuclear Lamina
- HuR (ELAVL1) binds and stabilizes mRNA
- WNT5A-dependent internalization of FZD4
- VEGFR2 mediated cell proliferation
- RHO GTPases Activate NADPH Oxidases
- Response to elevated platelet cytosolic Ca2+
- RET signaling
- ROBO receptors bind AKAP5
- ROBO receptors bind AKAP5
|
- Colforsin
- 2',5'-DIDEOXY-ADENOSINE 3'-MONOPHOSPHATE
|
- Phosphatidyl serine
- Vitamin E
- Tamoxifen
- Ingenol Mebutate
- Midostaurin
- Ellagic Acid
|
|
|
ADCY5 and RGS2 |
adenylate cyclase 5 |
regulator of G protein signaling 2 |
- Glucagon signaling in metabolic regulation
- PKA activation
- PKA activation in glucagon signalling
- Adenylate cyclase activating pathway
- Adenylate cyclase inhibitory pathway
- Adenylate cyclase inhibitory pathway
- Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
- Adrenaline,noradrenaline inhibits insulin secretion
- G alpha (s) signalling events
- G alpha (s) signalling events
- G alpha (i) signalling events
- G alpha (z) signalling events
- G alpha (z) signalling events
- Vasopressin regulates renal water homeostasis via Aquaporins
- Hedgehog 'off' state
- ADORA2B mediated anti-inflammatory cytokines production
- ADORA2B mediated anti-inflammatory cytokines production
- FCGR3A-mediated IL10 synthesis
|
- G alpha (q) signalling events
|
- Colforsin
- 2',5'-DIDEOXY-ADENOSINE 3'-MONOPHOSPHATE
|
|
|
|
ADCY5 and GNAI1 |
adenylate cyclase 5 |
G protein subunit alpha i1 |
- Glucagon signaling in metabolic regulation
- PKA activation
- PKA activation in glucagon signalling
- Adenylate cyclase activating pathway
- Adenylate cyclase inhibitory pathway
- Adenylate cyclase inhibitory pathway
- Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
- Adrenaline,noradrenaline inhibits insulin secretion
- G alpha (s) signalling events
- G alpha (s) signalling events
- G alpha (i) signalling events
- G alpha (z) signalling events
- G alpha (z) signalling events
- Vasopressin regulates renal water homeostasis via Aquaporins
- Hedgehog 'off' state
- ADORA2B mediated anti-inflammatory cytokines production
- ADORA2B mediated anti-inflammatory cytokines production
- FCGR3A-mediated IL10 synthesis
|
- PLC beta mediated events
- PLC beta mediated events
- Adenylate cyclase inhibitory pathway
- Adenylate cyclase inhibitory pathway
- G-protein activation
- ADP signalling through P2Y purinoceptor 12
- Adrenaline,noradrenaline inhibits insulin secretion
- Adrenaline,noradrenaline inhibits insulin secretion
- G alpha (s) signalling events
- G alpha (i) signalling events
- G alpha (i) signalling events
- G alpha (z) signalling events
- Regulation of insulin secretion
- Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding
- Extra-nuclear estrogen signaling
- ADORA2B mediated anti-inflammatory cytokines production
|
- Colforsin
- 2',5'-DIDEOXY-ADENOSINE 3'-MONOPHOSPHATE
|
- Guanosine-5'-Diphosphate
- Tetrafluoroaluminate Ion
|
|
|
ADCY5 and PRKCZ |
adenylate cyclase 5 |
protein kinase C zeta |
- Glucagon signaling in metabolic regulation
- PKA activation
- PKA activation in glucagon signalling
- Adenylate cyclase activating pathway
- Adenylate cyclase inhibitory pathway
- Adenylate cyclase inhibitory pathway
- Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
- Adrenaline,noradrenaline inhibits insulin secretion
- G alpha (s) signalling events
- G alpha (s) signalling events
- G alpha (i) signalling events
- G alpha (z) signalling events
- G alpha (z) signalling events
- Vasopressin regulates renal water homeostasis via Aquaporins
- Hedgehog 'off' state
- ADORA2B mediated anti-inflammatory cytokines production
- ADORA2B mediated anti-inflammatory cytokines production
- FCGR3A-mediated IL10 synthesis
|
- GPVI-mediated activation cascade
- TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
- TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
- VEGFR2 mediated cell proliferation
- RHO GTPases Activate NADPH Oxidases
- Estrogen-stimulated signaling through PRKCZ
- Estrogen-stimulated signaling through PRKCZ
|
- Colforsin
- 2',5'-DIDEOXY-ADENOSINE 3'-MONOPHOSPHATE
|
|
|
|
ADCY5 and GNAS |
adenylate cyclase 5 |
GNAS complex locus |
- Glucagon signaling in metabolic regulation
- PKA activation
- PKA activation in glucagon signalling
- Adenylate cyclase activating pathway
- Adenylate cyclase inhibitory pathway
- Adenylate cyclase inhibitory pathway
- Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
- Adrenaline,noradrenaline inhibits insulin secretion
- G alpha (s) signalling events
- G alpha (s) signalling events
- G alpha (i) signalling events
- G alpha (z) signalling events
- G alpha (z) signalling events
- Vasopressin regulates renal water homeostasis via Aquaporins
- Hedgehog 'off' state
- ADORA2B mediated anti-inflammatory cytokines production
- ADORA2B mediated anti-inflammatory cytokines production
- FCGR3A-mediated IL10 synthesis
|
- Glucagon signaling in metabolic regulation
- PKA activation in glucagon signalling
- Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
- Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
- Prostacyclin signalling through prostacyclin receptor
- Prostacyclin signalling through prostacyclin receptor
- G alpha (s) signalling events
- G alpha (s) signalling events
- G alpha (i) signalling events
- G alpha (z) signalling events
- Glucagon-type ligand receptors
- Vasopressin regulates renal water homeostasis via Aquaporins
- Hedgehog 'off' state
- ADORA2B mediated anti-inflammatory cytokines production
- ADORA2B mediated anti-inflammatory cytokines production
- Glucagon signaling in metabolic regulation
- PKA activation in glucagon signalling
- Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
- Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
- Prostacyclin signalling through prostacyclin receptor
- Prostacyclin signalling through prostacyclin receptor
- G alpha (s) signalling events
- G alpha (s) signalling events
- G alpha (i) signalling events
- G alpha (z) signalling events
- Glucagon-type ligand receptors
- Vasopressin regulates renal water homeostasis via Aquaporins
- Hedgehog 'off' state
- ADORA2B mediated anti-inflammatory cytokines production
- ADORA2B mediated anti-inflammatory cytokines production
|
- Colforsin
- 2',5'-DIDEOXY-ADENOSINE 3'-MONOPHOSPHATE
|
- Colforsin
- 2',5'-DIDEOXY-ADENOSINE 3'-MONOPHOSPHATE
|
|
- Fibrous dysplasia, polyostotic; Albright hereditary osteodystrophy
- Pseudohypoparathyroidism
- Progressive osseous heteroplasia (POH)
|
ADCY5 and PRKACA |
adenylate cyclase 5 |
protein kinase cAMP-activated catalytic subunit alpha |
- Glucagon signaling in metabolic regulation
- PKA activation
- PKA activation in glucagon signalling
- Adenylate cyclase activating pathway
- Adenylate cyclase inhibitory pathway
- Adenylate cyclase inhibitory pathway
- Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
- Adrenaline,noradrenaline inhibits insulin secretion
- G alpha (s) signalling events
- G alpha (s) signalling events
- G alpha (i) signalling events
- G alpha (z) signalling events
- G alpha (z) signalling events
- Vasopressin regulates renal water homeostasis via Aquaporins
- Hedgehog 'off' state
- ADORA2B mediated anti-inflammatory cytokines production
- ADORA2B mediated anti-inflammatory cytokines production
- FCGR3A-mediated IL10 synthesis
|
- PKA-mediated phosphorylation of CREB
- PKA-mediated phosphorylation of key metabolic factors
- Triglyceride catabolism
- PKA activation
- PKA activation in glucagon signalling
- DARPP-32 events
- Regulation of PLK1 Activity at G2/M Transition
- Loss of Nlp from mitotic centrosomes
- Recruitment of mitotic centrosome proteins and complexes
- Loss of proteins required for interphase microtubule organization from the centrosome
- Recruitment of NuMA to mitotic centrosomes
- Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
- Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
- Rap1 signalling
- Regulation of insulin secretion
- Vasopressin regulates renal water homeostasis via Aquaporins
- VEGFA-VEGFR2 Pathway
- CREB1 phosphorylation through the activation of Adenylate Cyclase
- CREB1 phosphorylation through the activation of Adenylate Cyclase
- Interleukin-3, Interleukin-5 and GM-CSF signaling
- Ion homeostasis
- Degradation of GLI1 by the proteasome
- Degradation of GLI2 by the proteasome
- GLI3 is processed to GLI3R by the proteasome
- Hedgehog 'off' state
- Anchoring of the basal body to the plasma membrane
- CD209 (DC-SIGN) signaling
- MAPK6/MAPK4 signaling
- RET signaling
- AURKA Activation by TPX2
- HDL assembly
- ROBO receptors bind AKAP5
- Loss of phosphorylation of MECP2 at T308
- Regulation of MECP2 expression and activity
- Regulation of glycolysis by fructose 2,6-bisphosphate metabolism
- ADORA2B mediated anti-inflammatory cytokines production
- ADORA2B mediated anti-inflammatory cytokines production
- FCGR3A-mediated IL10 synthesis
- FCGR3A-mediated IL10 synthesis
- Factors involved in megakaryocyte development and platelet production
|
- Colforsin
- 2',5'-DIDEOXY-ADENOSINE 3'-MONOPHOSPHATE
|
- Pentanal
- Balanol Analog 2
- Balanol Analog 8
- Phosphonothreonine
- Balanol Analog 1
- 3,5-Diiodotyrosine
- Balanol
- Dexfosfoserine
- S,S-(2-Hydroxyethyl)Thiocysteine
- Hydroxyfasudil
- (1S)-2-(1H-INDOL-3-YL)-1-{[(5-ISOQUINOLIN-6-YLPYRIDIN-3-YL)OXY]METHYL}ETHYLAMINE
- (2S)-1-{[5-(1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}-3-[(7AS)-7AH-INDOL-3-YL]PROPAN-2-AMINE
- (1S)-2-(1H-INDOL-3-YL)-1-[({5-[(E)-2-PYRIDIN-4-YLVINYL]PYRIDIN-3-YL}OXY)METHYL]ETHYLAMINE
- (2S)-1-(6H-INDOL-3-YL)-3-{[5-(7H-PYRAZOLO[3,4-C]PYRIDIN-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE
- (1S)-1-(1H-INDOL-3-YLMETHYL)-2-(2-PYRIDIN-4-YL-[1,7]NAPHTYRIDIN-5-YLOXY)-EHYLAMINE
- N-[(1S)-2-AMINO-1-(2,4-DICHLOROBENZYL)ETHYL]-5-[2-(METHYLAMINO)PYRIMIDIN-4-YL]THIOPHENE-2-CARBOXAMIDE
- 3-(1H-indol-3-yl)-4-{1-[2-(1-methylpyrrolidin-2-yl)ethyl]-1H-indol-3-yl}-1H-pyrrole-2,5-dione
- (4R,2S)-5'-(4-(4-CHLOROBENZYLOXY)PYRROLIDIN-2-YLMETHANESULFONYL)ISOQUINOLINE
- N-METHYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE
- (S)-1-PHENYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE
- 6-{4-[4-(4-CHLOROPHENYL)PIPERIDIN-4-YL]PHENYL}-9H-PURINE
- (2R)-2-(4-chlorophenyl)-2-[4-(1H-pyrazol-4-yl)phenyl]ethanamine
- (2S)-2-(4-chlorophenyl)-2-[4-(1H-pyrazol-4-yl)phenyl]ethanamine
- 4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE
- (2R)-2-(4-CHLOROPHENYL)-2-PHENYLETHANAMINE
- (S)-2-METHYL-1-[(4-METHYL-5-ISOQUINOLINE)SULFONYL]-HOMOPIPERAZINE
- ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE
- N-[2-(4-BROMOCINNAMYLAMINO)ETHYL]-5-ISOQUINOLINE SULFONAMIDE
- 5-(2-methylpiperazine-1-sulfonyl)isoquinoline
- N-[2-(METHYLAMINO)ETHYL]-5-ISOQUINOLINESULFONAMIDE
- 2-[4-(3-METHYL-1H-PYRAZOL-4-YL)PHENYL]ETHANAMINE
- (2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE
- 3-pyridin-4-yl-1H-indazole
- 5-benzyl-1,3-thiazol-2-amine
- 1-[4-(4-chlorophenyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine
- 1-[4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine
- 4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-aminium
- Fasudil
- Myristic acid
- (2S)-1-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}-3-PHENYLPROPAN-2-AMINE
- 3-PYRIDIN-4-YL-2,4-DIHYDRO-INDENO[1,2-.C.] PYRAZOLE
- (R)-TRANS-4-(1-AMINOETHYL)-N-(4-PYRIDYL) CYCLOHEXANECARBOXAMIDE
- Ellagic Acid
|
|
|
ADORA1 and P2RY1 |
adenosine A1 receptor |
purinergic receptor P2Y1 |
- Adenosine P1 receptors
- G alpha (i) signalling events
|
- G alpha (q) signalling events
- P2Y receptors
- ADP signalling through P2Y purinoceptor 1
- ADP signalling through P2Y purinoceptor 1
|
- Caffeine
- Theophylline
- Adenosine
- Dyphylline
- Pentoxifylline
- Enprofylline
- Gabapentin
- Aminophylline
- Oxtriphylline
- Theobromine
- Defibrotide
- Tecadenoson
- Naxifylline
- Tonapofylline
- Rolofylline
|
|
|
|
PARP1 and RNF144A |
poly(ADP-ribose) polymerase 1 |
ring finger protein 144A |
- POLB-Dependent Long Patch Base Excision Repair
- Downregulation of SMAD2/3:SMAD4 transcriptional activity
- SUMOylation of DNA damage response and repair proteins
- HDR through MMEJ (alt-NHEJ)
- DNA Damage Recognition in GG-NER
- Formation of Incision Complex in GG-NER
- Dual Incision in GG-NER
|
- E3 ubiquitin ligases ubiquitinate target proteins
|
- Theophylline
- Zinc
- Carba-Nicotinamide-Adenine-Dinucleotide
- NU1025
- Nicotinamide
- 2-{3-[4-(4-Fluorophenyl)-3,6-Dihydro-1(2h)-Pyridinyl]Propyl}-8-Methyl-4(3h)-Quinazolinone
- 3-Methoxybenzamide
- 2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide
- 3,4-Dihydro-5-Methyl-Isoquinolinone
- 2-(3'-Methoxyphenyl) Benzimidazole-4-Carboxamide
- 6-AMINO-BENZO[DE]ISOQUINOLINE-1,3-DIONE
- Veliparib
- trans-4-(7-carbamoyl-1H-benzimidazol-2-yl)-1-propylpiperidinium
- 5-FLUORO-1-[4-(4-PHENYL-3,6-DIHYDROPYRIDIN-1(2H)-YL)BUTYL]QUINAZOLINE-2,4(1H,3H)-DIONE
- Olaparib
- Niraparib
- Rucaparib
|
|
|
|
PARP1 and NFATC1 |
poly(ADP-ribose) polymerase 1 |
nuclear factor of activated T cells 1 |
- POLB-Dependent Long Patch Base Excision Repair
- Downregulation of SMAD2/3:SMAD4 transcriptional activity
- SUMOylation of DNA damage response and repair proteins
- HDR through MMEJ (alt-NHEJ)
- DNA Damage Recognition in GG-NER
- Formation of Incision Complex in GG-NER
- Dual Incision in GG-NER
|
- Calcineurin activates NFAT
- Calcineurin activates NFAT
- FCERI mediated Ca+2 mobilization
- Ca2+ pathway
- CLEC7A (Dectin-1) induces NFAT activation
|
- Theophylline
- Zinc
- Carba-Nicotinamide-Adenine-Dinucleotide
- NU1025
- Nicotinamide
- 2-{3-[4-(4-Fluorophenyl)-3,6-Dihydro-1(2h)-Pyridinyl]Propyl}-8-Methyl-4(3h)-Quinazolinone
- 3-Methoxybenzamide
- 2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide
- 3,4-Dihydro-5-Methyl-Isoquinolinone
- 2-(3'-Methoxyphenyl) Benzimidazole-4-Carboxamide
- 6-AMINO-BENZO[DE]ISOQUINOLINE-1,3-DIONE
- Veliparib
- trans-4-(7-carbamoyl-1H-benzimidazol-2-yl)-1-propylpiperidinium
- 5-FLUORO-1-[4-(4-PHENYL-3,6-DIHYDROPYRIDIN-1(2H)-YL)BUTYL]QUINAZOLINE-2,4(1H,3H)-DIONE
- Olaparib
- Niraparib
- Rucaparib
|
|
|
|
PARP1 and ZBTB9 |
poly(ADP-ribose) polymerase 1 |
zinc finger and BTB domain containing 9 |
- POLB-Dependent Long Patch Base Excision Repair
- Downregulation of SMAD2/3:SMAD4 transcriptional activity
- SUMOylation of DNA damage response and repair proteins
- HDR through MMEJ (alt-NHEJ)
- DNA Damage Recognition in GG-NER
- Formation of Incision Complex in GG-NER
- Dual Incision in GG-NER
|
|
- Theophylline
- Zinc
- Carba-Nicotinamide-Adenine-Dinucleotide
- NU1025
- Nicotinamide
- 2-{3-[4-(4-Fluorophenyl)-3,6-Dihydro-1(2h)-Pyridinyl]Propyl}-8-Methyl-4(3h)-Quinazolinone
- 3-Methoxybenzamide
- 2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide
- 3,4-Dihydro-5-Methyl-Isoquinolinone
- 2-(3'-Methoxyphenyl) Benzimidazole-4-Carboxamide
- 6-AMINO-BENZO[DE]ISOQUINOLINE-1,3-DIONE
- Veliparib
- trans-4-(7-carbamoyl-1H-benzimidazol-2-yl)-1-propylpiperidinium
- 5-FLUORO-1-[4-(4-PHENYL-3,6-DIHYDROPYRIDIN-1(2H)-YL)BUTYL]QUINAZOLINE-2,4(1H,3H)-DIONE
- Olaparib
- Niraparib
- Rucaparib
|
|
|
|
ADRA1D and SNTG1 |
adrenoceptor alpha 1D |
syntrophin gamma 1 |
- Adrenoceptors
- G alpha (q) signalling events
- G alpha (12/13) signalling events
|
|
- Amphetamine
- Midodrine
- Cabergoline
- Dapiprazole
- Amitriptyline
- Alfuzosin
- Norepinephrine
- Mirtazapine
- Phenylephrine
- Promazine
- Prazosin
- Imipramine
- Chlorpromazine
- Nortriptyline
- Amoxapine
- Clonidine
- Doxazosin
- Labetalol
- Nicardipine
- Verapamil
- Epinephrine
- Phentolamine
- Ergotamine
- Tamsulosin
- Methoxamine
- Propiomazine
- Fenoldopam
- Quinidine
- Phenoxybenzamine
- Maprotiline
- Oxymetazoline
- Ergoloid mesylate
- Carvedilol
- Doxepin
- Desipramine
- Terazosin
- Pergolide
- Bromocriptine
- Quetiapine
- Mephentermine
- Methotrimeprazine
- Dronedarone
- R450
- Epicept NP-1
- Sertindole
- Mianserin
- Silodosin
- Droxidopa
- Xylometazoline
- Perospirone
- Dosulepin
- Etoperidone
- Cirazoline
- Synephrine
- Tiapride
|
|
|
|
ADRA2A and GNG2 |
adrenoceptor alpha 2A |
G protein subunit gamma 2 |
- Adrenoceptors
- Adrenaline signalling through Alpha-2 adrenergic receptor
- Adrenaline,noradrenaline inhibits insulin secretion
- G alpha (i) signalling events
- G alpha (z) signalling events
- Surfactant metabolism
|
- Activation of G protein gated Potassium channels
- Glucagon signaling in metabolic regulation
- G-protein activation
- Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
- Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
- ADP signalling through P2Y purinoceptor 12
- G beta:gamma signalling through PI3Kgamma
- Prostacyclin signalling through prostacyclin receptor
- Prostacyclin signalling through prostacyclin receptor
- Adrenaline,noradrenaline inhibits insulin secretion
- Adrenaline,noradrenaline inhibits insulin secretion
- Ca2+ pathway
- Ca2+ pathway
- G alpha (q) signalling events
- G alpha (12/13) signalling events
- G beta:gamma signalling through PLC beta
- G alpha (s) signalling events
- ADP signalling through P2Y purinoceptor 1
- ADP signalling through P2Y purinoceptor 1
- G alpha (i) signalling events
- G alpha (z) signalling events
- Glucagon-type ligand receptors
- Thromboxane signalling through TP receptor
- Vasopressin regulates renal water homeostasis via Aquaporins
- Thrombin signalling through proteinase activated receptors (PARs)
- Thrombin signalling through proteinase activated receptors (PARs)
- Presynaptic function of Kainate receptors
- Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding
- G beta:gamma signalling through BTK
- G beta:gamma signalling through CDC42
- Extra-nuclear estrogen signaling
- ADORA2B mediated anti-inflammatory cytokines production
- Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits
|
- Amphetamine
- Bethanidine
- Ziprasidone
- Cabergoline
- Ropinirole
- Dihydroergotamine
- Amitriptyline
- Olanzapine
- Clozapine
- Norepinephrine
- Mirtazapine
- Phenylpropanolamine
- Loxapine
- Pramipexole
- Dipivefrin
- Prazosin
- Chlorpromazine
- Brimonidine
- Nortriptyline
- Amoxapine
- Amoxapine
- Clonidine
- Lisuride
- Guanabenz
- Dexmedetomidine
- Trazodone
- Epinephrine
- Phentolamine
- Ergotamine
- Tizanidine
- Apomorphine
- Trimipramine
- Risperidone
- Epinastine
- Tolazoline
- Fenoldopam
- Dobutamine
- Pseudoephedrine
- Benzphetamine
- Phenoxybenzamine
- Maprotiline
- Oxymetazoline
- Apraclonidine
- Methyldopa
- Guanfacine
- Ergoloid mesylate
- Carvedilol
- Doxepin
- Nefazodone
- Desipramine
- Pergolide
- Bromocriptine
- Quetiapine
- Aripiprazole
- Paliperidone
- Ephedra
- Mephentermine
- Yohimbine
- Methotrimeprazine
- 4-Methoxyamphetamine
- Methamphetamine
- Propericiazine
- Zuclopenthixol
- Dronedarone
- Lofexidine
- Epicept NP-1
- Mianserin
- Asenapine
- Droxidopa
- Flupirtine
- Esmirtazapine
- Xylometazoline
- Levonordefrin
- Naphazoline
- Lurasidone
- Dosulepin
- Etoperidone
- Cirazoline
- Moxonidine
- Setiptiline
- Rilmenidine
- Tiapride
|
|
|
|